摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(Cyclohexylthiocarbamoyl)-1,2,4-triazol | 63976-78-3

中文名称
——
中文别名
——
英文名称
1-(Cyclohexylthiocarbamoyl)-1,2,4-triazol
英文别名
[1,2,4]triazole-1-carbothioic acid cyclohexylamide;N-cyclohexyl-1,2,4-triazole-1-carbothioamide
1-(Cyclohexylthiocarbamoyl)-1,2,4-triazol化学式
CAS
63976-78-3
化学式
C9H14N4S
mdl
——
分子量
210.303
InChiKey
QLEZOOJSWPRITJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    78-79 °C
  • 沸点:
    355.5±25.0 °C(Predicted)
  • 密度:
    1.36±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    74.8
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    1H-1,2,4-三唑环己基异硫氰酸脂 反应 30.0h, 以3.7%的产率得到1-(Cyclohexylthiocarbamoyl)-1,2,4-triazol
    参考文献:
    名称:
    Synthesis and Pharmacological Activity of Triazole Derivatives Inhibiting Eosinophilia
    摘要:
    In order to develop novel antiasthmatic agents based on a new mechanism of action, a series of 3-substituted 5-amino-1-[(methylamino)(thiocarbonyl)]-1H-1,2,4-triazole derivatives were synthesized and evaluated in a model in which eosinophilia was induced in the ah-way through intravenous (iv) injection of Sephadex particles on days 0, 2, and 5. After screening of several hundred derivatives, we finally identified the highly potent eosinophilia inhibitor 5-amino-3-(4-chlorophenyl)-1-[(methylamino)(thiocarbonyl)]-1H-triazole (23c, GCC-AP0341), which had ID50 values of 0.3 and 0.07 mg/kg when administered orally (os) and intraperitoneally tip), respectively. This compound showed complete inhibition of the hypersensitivity induced by ascaris inhalation at an ip dose of 1 mg/kg as well as low toxicity, with an LD(50) value of > 2.0 g/kg in mice. Extensive study of its mechanism of action revealed that 23c inhibited eosinophil survival induced by interleukin-5 (IL-5), but had little or no effect on leukotriene D-4 (LTD(4)) or platelet-activating factor (PAF)-induced responses. Taken together, these results suggest 23e as a novel candidate for the treatment of chronic asthma. Further studies are now underway.
    DOI:
    10.1021/jm9507993
点击查看最新优质反应信息

文献信息

  • LARSEN C.; STELION K.; HARPP D., J. ORG. CHEM., 1978, 43, NO 2, 337-339
    作者:LARSEN C.、 STELION K.、 HARPP D.
    DOI:——
    日期:——
查看更多